Cloxicure

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Aktīvā sastāvdaļa:

CLOXACILLIN AS THE BENZATHINE SALT

Pieejams no:

NORBROOK LABORATORIES AUSTRALIA PTY LIMITED

Zāļu forma:

MISC. INTRA MAMMARY

Kompozīcija:

CLOXACILLIN AS THE BENZATHINE SALT ANTIBIOTIC Active 600.0 mg

Vienības iepakojumā:

#200; #syringes; *20; *syringes

Klase:

VM - Veterinary Medicine

Ārstniecības joma:

ANTIBIOTIC & RELATED

Produktu pārskats:

Poison schedule: 4; Withholding period: WITHHOLDING PERIODS MILK: DO NOT USE in lactating cows or within 35 days of cal ving. After calving, colostrum or milk from treated dry cows MUST NOT BE USED f or human consumption or processing for 96 hours (8 milkings). If premature or u nscheduled calving occurs, consult the prescribing veterinarian for advice on h andling milk for bobby calves. MEAT: DO NOT USE less than 30 days before slaugh ter for human consumption. EXPORT SLAUG HTER INTERVAL (ESI): An ESI has not been established for this product. Note—obs erving the meat withholding period may n ot be sufficient to mitigate potential risks to export trade. Trade advice shou ld be sought from NORBROOK LABORATORIES AUSTRALIA PTY LIMITED on 1800 665 866 b efore using this product.; Host/pest details: DAIRY CATTLE: [MASTITIS]

Autorizācija statuss:

Registered

Autorizācija datums:

2023-07-01

Lietošanas instrukcija

Cloxicure
85227 / 112674
Product Name:
APVMA Approval No:
Label Name:
Cloxicure
Signal Headings:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
600 mg CLOXACILLIN (as benzathine salt)
Claims:
For the control of mastitis in dairy cows caused by Streptococcus
spp., Staphylococcus
spp. (including penicillin resistant strains), Arcanobacterium spp.
and other organisms
susceptible to cloxacillin.
Net Contents:
20 syringes 5.4 g each
200 syringes 5.4 g each
Directions for Use:
Restraints:
DO NOT USE in lactating cows or cows due to calve within 35 days after
treatment.
Contraindications:
This product is contraindicated for use in cows allergic to
penicillin.
Precautions:
If Cloxicure is accidentally administered to a lactating animal or
within 35 days of calving,
contact the prescribing veterinarian for advice.
Side Effects:
Dosage and
Administration:
Infuse the contents of one syringe per quarter immediately after the
final milking of a
lactation. Prior to infusing Cloxicure clean and disinfect the teat.
Infuse one syringe of
Cloxicure into each quarter then teat dip or spray the teat. It is
normally unnecessary and RLP APPROVED
undesirable to introduce further treatment during the dry period.
Cloxicure is presented in
syringes with a variable tip. This variable tip allows for either full
or partial insertion into the
teat orifice. Partial insertion only is preferable, as it may prevent
unnecessary damage to
the teat orifice. Full insertion will be needed for large teat
orifices.
There is evidence that partial insertion can reduce the incidence of
Staphylococcus aureus
and Streptococcus uberis infections (Boddie et. al., 1990). Any
variation by the prescribing
veterinarian to the approved dose, frequency, duration, route, disease
or target species
may require extending the approved withholding period.
General Directions:
Presentation:
CLOXICURE is a stable intramammary suspension prepared under sterile
conditions. Each
5.4 g syringe contains 600 mg CLOXACILLI